Dacon Oil and Gas Company main aim is to publish the peer review articles in the field of analytical and pharmaceutical sciences by enlightening the people about latest trends in pharmaceuticals. Main scope of journal is very broad which is engaged in preformulation studies, stability and degradation of bulk drugs, method development and validation,.
The significant fields such
- 1 Pharmaceutical Technology
- 2 Analytical Chemistry
- 3 Computational chemistry
- 4 Molecular Drug Design
- 5 Biopharmaceutics, biodistribution of molecules
- 6 Pharmacognosy
Dacon Oil and Gas Company pleasurably welcomes research papers, review articles, short communications, mini-reviews, opinions, letter to editors, etc.
Why Choose This Service
Dacon Research is America's top choice for qualitative research services, servicing the pharmaceutical industry in America from coast to coast for nearly 30 years.
We use proven and innovative technologies to safely and responsibly access and produce oil and natural gas in a wide range of different geologic settings
We leverage technologies where they can create the most value for our operations and allow us to operate with great stability and enable us to optimize production
Our corporate strategy addresses the fundamentals that we must have in place to manage our risks and help us deliver our strategy and a significant valuable spin-off for our investors.
Worldwide Delivery. Product Support. Engineering & Production. Fast Responding 24/7. Dacon Oil and Gas Company and manufactures a full range equipment.
Radiopharmaceuticals are compounds that have a radionuclide and may be gamma-radiation emitter (γ) or positrons emitter (β+), linked to a molecule with specific diagnostic and therapeutic purposes. The progress in the use of radiopharmaceuticals has culminated to a sector in common with other types of drugs: regulation and surveillance.
However, only in 2003 the Unit of Pharmacovigilance disclosed information pertinent to the leaflet of radiopharmaceuticals and the paramount importance of informational reports for the renewal of medicines. After the designated Management Pharmacovigilance, in 2007, there were Resolutions to standardize and assist this whole process, which today, is indispensable to any holder of record of medication as provided in RDC nº 4 of February 10, 2009
Thus, there was a rupture in the monopoly of production, marketing and use of radioisotopes of short half-life, for medical, agricultural and industrial in Brazil, designed by Constitutional Amendment 49 (Santos-Oliveira, Carneiro, Leão, 2008). Originate from the Proposed Constitutional Amendment 199/03, which removes the Union's the monopoly of manipulation of radioisotopes with short half-life, Constitutional Amendment 49 facilitated the creation of new nuclear medicine centers that offer the service of tomography to the population.